52.41
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt NVO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Novo Nordisk Adr Aktie (NVO) Neueste Nachrichten
Why Novo Nordisk Flew Almost 3% Higher on Friday - The Motley Fool
European ADRs Gained Ground In The US Trading Session - Finimize
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines – NVO - FinancialContent
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - GlobeNewswire Inc.
European ADRs Slipped As Top Movers Took Center Stage - Finimize
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - GlobeNewswire Inc.
Real time scanner hits for Novo Nordisk A s (b Shares) Adrhedged explainedBuy/Sell Zone Confirmation Technical Analysis - Newser
Novo Nordisk A/S Common Stock (NYSE:NVO) Stock Quote - FinancialContent
Will a bounce in Novo Nordisk A s (b Shares) Adrhedged offer an exitNext Day Momentum Stock Forecasting Report - Newser
European ADRs Tick Up As Healthcare And Industrials Shine - Finimize
Applying sector rotation models to Novo Nordisk A s (b Shares) AdrhedgedPredictive AI Signals for Short-Term Trading - Newser
Should You Sell Eli Lilly and Buy Novo Nordisk Stock After Q2? - Money Morning
Why Novo Nordisk A s (b Shares) Adrhedged stock attracts strong analyst attentionIntraday Strategy with Real Time Monitoring - Newser
Does Novo Nordisk A s (b Shares) Adrhedged qualify in momentum factor screeningFree Market Surge Signal for Swing Traders - Newser
Published on: 2025-08-06 19:02:41 - Newser
Novo Nordisk Earnings: CVS Deal, Oral Semaglutide Support Growth Despite Compounding Uncertainty - Morningstar
Is Novo Nordisk A s (b Shares) Adrhedged trending in predictive chart modelsFree AI Screening for Swing Trade Picks - Newser
Novo Nordisk lowers 2025 sales outlook, ADR price falls 21.83%. - AInvest
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/SNVO - cnhinews.com
Novo Nordisk ADR earnings beat by $0.04, revenue fell short of estimates - Investing.com
Novo Nordisk A/S Announces 7% Increase in Interim Dividend for 2025, Payment Dates Set - AInvest
Novo Nordisk ADR earnings beat by $11.56, revenue topped estimates - Investing.com India
Novo Nordisk Q2 Earnings Beat, Sales Miss, GLP-1 Drugs Face US Hurdles - Yahoo Finance
How to monitor Novo Nordisk A s (b Shares) Adrhedged with trend dashboardsFree Alpha Focused Technical Trade Signals - Newser
Chart based exit strategy for Novo Nordisk A s (b Shares) AdrhedgedVolume Confirmed Setup with Entry Confidence - Newser
Novo Nordisk A s (b Shares) Adrhedged’s volatility index tracking explainedMomentum Prediction Based on AI Backtesting - Newser
Novo faces shareholder lawsuit over guidance cut - MSN
Novo Nordisk ADR’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com
Is Novo Nordisk A s (b Shares) Adrhedged forming a bottoming baseHistorical Stock Summary and ROI Review - Newser
Will earnings trigger a reversal in Novo Nordisk A s (b Shares) AdrhedgedMarket Correction Proof Stock Screening Analysis - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):